During a Community Case Forum event in partnership with the Texas Society of Clinical Oncology, Natalie Vokes, MD, discussed trials of targeted agents for EGFR-mutant lung cancer.
Analysts at Zacks Research raised their Q3 2026 EPS estimates for shares of Exxon Mobil in a research note issued to ...
Analysts at Zacks Research cut their Q1 2026 earnings per share (EPS) estimates for Exxon Mobil in a research note issued on ...
Alternative RNA splicing is like a movie editor cutting and rearranging scenes from the same footage to create different ...
Discover top Dividend Aristocrats with high yields and potential gains by 2026. Learn which stocks are ideally priced and ...
HANOI (Reuters) - Top U.S. tech, defence and energy companies including Boeing (NYSE: BA) and Apple (NASDAQ: AAPL) will join ...
OCI reported FY 2024 Continuing Operations (European Nitrogen and Corporate Entities segments) revenue of $975 million, an ...
Freehold Royalties Ltd. (Freehold or the Company) (TSX:FRU) announces fourth quarter and year-end results for the period ended December 31, 2024.
ExxonMobil (NYSE: XOM) has a bold view of its future. The energy giant wants to deliver an incremental $20 billion of ...
GTLS is set to provide its NRU and helium process technology for the Dry Piney Helium and Carbon Sequestration Project in Sublette County, WY.
Energy giants Exxon Mobil (XOM) and Chevron (CVX ... Microsoft’s stock has a consensus Strong Buy rating among 31 Wall Street ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results